MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.190
-0.080 (-6.30%)
At close: Jun 27, 2025, 4:00 PM
1.210
+0.020 (1.68%)
After-hours: Jun 27, 2025, 7:42 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $75.08 million as of June 27, 2025. Its market cap has decreased by -75.69% in one year.
Market Cap
75.08M
Enterprise Value
-41.60M
1-Year Change
-75.69%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $75.08M, a decrease of -87.49%. That is a compound annual growth rate of -16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 75.10M | -63.19% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |